Veterinary Pain Management Drugs Market By product type (Opioids, 2-Adrenergic Agonists, Local Anesthetics, Nonsteroidal Anti-Inflammatory Drugs (NSIDs), Sedatives, Corticosteroids, Other), by Application/End-Use (Veterinary Hospitals, Veterinary Clinics, For Retail), by Route of administration (Oral Preparations, Parenteral Preparations), by Animal Type (Livestock, Other animals), Industry Trends, Estimation & Forecast, 2017 - 2025

Veterinary Pain Management Drugs Market is expected to grow with a CAGR of 7% during the forecast period of 2018 to 2025.

Market Overview:

Veterinary pain management drugs are an important part of veterinary therapeutics used for controlling pain and inflammation in animals which may occur due to surgeries, arthritis and cancer. The veterinary pain management drugs market is witnessing a positive impact on its growth due to increasing incidences of animal diseases and surgeries which require pain management medications. Moreover, the surging pet culture all over the globe and rising dependence on animals for animal derived products such as milk, meat and others, the population of companion animals as well as livestock is increasing. As per the data cited by American Society for the Prevention of Cruelty to Animals, around 6.5 million companion animals enter U.S. animal shelters nationwide every year and approximately, 3.2 million are adopted each year. With this, the demand for veterinary pain management drugs is expected to witness sustained growth in coming years. However, high cost of certain drugs and the associated side effects which could be severe are the challenges faced by the market. Though, the emerging markets such as India and even China are presently much smaller compared to the developed nations, in terms of demand for these drugs, these markets are likely to offer lucrative business opportunities to market players in coming years. Market players are introducing products targeting various animals and their specific diseases in order to gain market share. In 2017, Elanco Animal Health launched pain management drug for osteoarthritis, targeting dogs of all ages. The report provides detailed qualitative and quantitative analysis of the veterinary pain management drugs market. Market size and forecast has been provided for the period - (2017 – 2025) for segments namely product type, application, route of administration and animal type across all the major countries.

Veterinary Pain Management Drugs Market Segmentation

By product type •Opioids •2-Adrenergic Agonists •Local Anesthetics •Nonsteroidal Anti-Inflammatory Drugs (NSIDs) •Sedatives •Corticosteroids •Other By Application/End-Use •Veterinary Hospitals •Veterinary Clinics •For Retail By Route of administration •Oral Preparations •Parenteral Preparations By Animal Type •Livestock •Other animals By Geography •North America oU.S. oCanada oMexico •Europe oU.K. oFrance oGermany oItaly oSpain oRest of Europe •Asia-Pacific oChina oJapan oIndia oKorea oRest of APAC •South America oBrazil oRest of South America •Rest of the World oMiddle East oAfrica

CHAPTER 1. INTRODUCTION
1.1. RESEARCH METHODOLOGY
1.1.1. ERC DESK RESEARCH
1.1.2. ERC DATA SYNTHESIS
1.1.3. DATA VALIDATION AND MARKET FEEDBACK
1.1.4. ERC DATA SOURCES

CHAPTER 2. VETERINARY PAIN MANAGEMENT DRUGS MARKET OVERVIEW
2.1. VETERINARY PAIN MANAGEMENT DRUGS MARKET INTRODUCTION
2.2. GLOBAL VETERINARY PAIN MANAGEMENT DRUGS MARKET PRODUCTION AND GROWTH RATE, 2017-2025
2.2.1. GLOBAL VETERINARY PAIN MANAGEMENT DRUGS PRODUCTION (VOLUME) AND GROWTH RATE (%), (2017-2025)
2.3. GLOBAL VETERINARY PAIN MANAGEMENT DRUGS MARKET CAPACITY AND GROWTH RATE, 2017-2025
2.3.1. GLOBAL VETERINARY PAIN MANAGEMENT DRUGS CAPACITY (VOLUME) AND GROWTH RATE (%), (2017-2025)
2.4. GLOBAL VETERINARY PAIN MANAGEMENT DRUGS MARKET REVENUE AND GROWTH RATE, 2017-2025
2.4.1. GLOBAL VETERINARY PAIN MANAGEMENT DRUGS MARKET REVENUE (MILLION USD) AND GROWTH RATE (%), (2017-2025)
2.5. GLOBAL VETERINARY PAIN MANAGEMENT DRUGS MARKET CONSUMPTION AND GROWTH RATE, 2017-2025
2.5.1. GLOBAL VETERINARY PAIN MANAGEMENT DRUGS CONSUMPTION (VOLUME) AND GROWTH RATE (%), (2017-2025)

CHAPTER 3. GLOBAL VETERINARY PAIN MANAGEMENT DRUGS MARKET BY PRODUCT TYPE, 2017-2025
3.1. OPIOIDS
3.2. 2-ADRENERGIC AGONISTS
3.3. LOCAL ANESTHETICS
3.4. GLOBAL VETERINARY PAIN MANAGEMENT DRUGS MARKET REVENUE BY PRODUCT TYPE, 2017-2025
3.4.1. GLOBAL VETERINARY PAIN MANAGEMENT DRUGS MARKET REVENUE (MILLION USD) AND SHARE (%) BY PRODUCT TYPE, 2017-2025
3.4.2. OPIOIDS MARKET REVENUE AND GROWTH RATE, 2017-2025
3.4.3. 2-ADRENERGIC AGONISTS MARKET REVENUE AND GROWTH RATE, 2017-2025
3.4.4. LOCAL ANESTHETICS MARKET REVENUE AND GROWTH RATE, 2017-2025
3.5. GLOBAL VETERINARY PAIN MANAGEMENT DRUGS MARKET PRODUCTION BY PRODUCT TYPE, 2017-2025
3.5.1. GLOBAL VETERINARY PAIN MANAGEMENT DRUGS MARKET PRODUCTION (VOLUME) AND SHARE (%) BY PRODUCT TYPE, 2017-2025
3.5.2. OPIOIDS MARKET PRODUCTION AND GROWTH RATE, 2017-2025
3.5.3. 2-ADRENERGIC AGONISTS MARKET PRODUCTION AND GROWTH RATE, 2017-2025
3.5.4. LOCAL ANESTHETICS MARKET PRODUCTION AND GROWTH RATE, 2017-2025
Note: Similar information coverage has been provided for other product type segments.

CHAPTER 4. GLOBAL VETERINARY PAIN MANAGEMENT DRUGS MARKET BY APPLICATION, 2017-2025
4.1. VETERINARY HOSPITALS
4.2. VETERINARY CLINICS
4.3. RETAIL
4.4. GLOBAL VETERINARY PAIN MANAGEMENT DRUGS MARKET REVENUE BY APPLICATION, 2017-2025
4.4.1. GLOBAL VETERINARY PAIN MANAGEMENT DRUGS MARKET REVENUE (MILLION USD) AND SHARE (%) BY APPLICATION, 2017-2025
4.4.2. VETERINARY HOSPITALS MARKET REVENUE AND GROWTH RATE, 2017-2025
4.4.3. VETERINARY CLINICS MARKET REVENUE AND GROWTH RATE, 2017-2025
4.4.4. RETAIL MARKET REVENUE AND GROWTH RATE, 2017-2025
4.5. GLOBAL VETERINARY PAIN MANAGEMENT DRUGS MARKET CONSUMPTION BY APPLICATION, 2017-2025
4.5.1. GLOBAL VETERINARY PAIN MANAGEMENT DRUGS MARKET CONSUMPTION (VOLUME) AND SHARE (%) BY APPLICATION, 2017-2025
4.5.2. VETERINARY HOSPITALS MARKET CONSUMPTION AND GROWTH RATE, 2017-2025
4.5.3. VETERINARY CLINICS MARKET CONSUMPTION AND GROWTH RATE, 2017-2025
4.5.4. RETAIL MARKET CONSUMPTION AND GROWTH RATE, 2017-2025
Note: Similar information coverage has been provided for route of administration and animal type segments.

CHAPTER 5. GLOBAL VETERINARY PAIN MANAGEMENT DRUGS MARKET BY REGION, 2017-2025
5.1. NORTH AMERICA
5.1.1. U.S.
5.1.2. CANADA
5.1.3. MEXICO
5.2. EUROPE
5.2.1. U.K.
5.2.2. FRANCE
5.2.3. GERMANY
5.2.4. ITALY
5.2.5. SPAIN
5.2.6. REST OF EUROPE
5.3. ASIA PACIFIC
5.3.1. CHINA
5.3.2. JAPAN
5.3.3. INDIA
5.3.4. KOREA
5.3.5. REST OF APAC
5.4. SOUTH AMERICA
5.4.1. BRAZIL
5.4.2. REST OF SOUTH AMERICA
5.5. REST OF THE WORLD
5.5.1. MIDDLE EAST
5.5.2. AFRICA
5.6. GLOBAL VETERINARY PAIN MANAGEMENT DRUGS MARKET REVENUE BY REGION, 2017-2025
5.6.1. GLOBAL VETERINARY PAIN MANAGEMENT DRUGS MARKET REVENUE (MILLION USD) AND SHARE (%) BY REGION, 2017-2025
5.6.2. NORTH AMERICA MARKET REVENUE AND GROWTH RATE, 2017-2025
5.6.3. EUROPE MARKET REVENUE AND GROWTH RATE, 2017-2025
5.6.4. ASIA PACIFIC MARKET REVENUE AND GROWTH RATE, 2017-2025
5.6.5. SOUTH AMERICA MARKET REVENUE AND GROWTH RATE, 2017-2025
5.6.6. REST OF THE WORLD MARKET REVENUE AND GROWTH RATE, 2017-2025

CHAPTER 6. GLOBAL VETERINARY PAIN MANAGEMENT DRUGS MARKET PRODUCTION AND CONSUMPTION ANALYSIS BY REGION, 2017-2025
6.1. GLOBAL VETERINARY PAIN MANAGEMENT DRUGS MARKET PRODUCTION ANALYSIS BY REGION, 2017-2025
6.1.1. GLOBAL VETERINARY PAIN MANAGEMENT DRUGS MARKET PRODUCTION (VOLUME) AND SHARE (%) BY REGION, 2017-2025
6.1.2. GLOBAL VETERINARY PAIN MANAGEMENT DRUGS MARKET CONSUMPTION (VOLUME) AND SHARE (%) BY REGION, 2017-2025
6.1.3. NORTH AMERICA MARKET PRODUCTION AND CONSUMPTION, 2017-2025
6.1.4. EUROPE MARKET PRODUCTION AND CONSUMPTION, 2017-2025
6.1.5. ASIA PACIFIC MARKET PRODUCTION AND CONSUMPTION, 2017-2025
6.1.6. SOUTH AMERICA MARKET PRODUCTION AND CONSUMPTION, 2017-2025
6.1.7. REST OF THE WORLD MARKET PRODUCTION AND CONSUMPTION, 2017-2025

CHAPTER 7. MARKET DETERMINANTS
7.1. MARKET DRIVERS
7.2. MARKET RESTRAINTS
7.3. MARKET OPPORTUNITIES
7.4. MARKET DETERMINANTS RADAR CHART

CHAPTER 8. GLOBAL VETERINARY PAIN MANAGEMENT DRUGS MARKET COMPETITION BY MANUFACTURERS
8.1. GLOBAL VETERINARY PAIN MANAGEMENT DRUGS PRODUCTION AND SHARE BY MANUFACTURERS (2017-2025)
8.1.1. GLOBAL VETERINARY PAIN MANAGEMENT DRUGS PRODUCTION (VOLUME) AND SHARE (%) BY MANUFACTURERS (2017-2025)
8.2. GLOBAL VETERINARY PAIN MANAGEMENT DRUGS REVENUE AND SHARE BY MANUFACTURERS (2017-2025)
8.2.1. GLOBAL VETERINARY PAIN MANAGEMENT DRUGS REVENUE (MILLION USD) AND SHARE (%) BY MANUFACTURERS (2017-2025)
8.3. VETERINARY PAIN MANAGEMENT DRUGS MARKET COMPETITIVE SITUATION AND TRENDS
8.3.1. VETERINARY PAIN MANAGEMENT DRUGS MARKET SHARE (%) OF TOP 3 MANUFACTURERS
8.3.2. VETERINARY PAIN MANAGEMENT DRUGS MARKET SHARE (%) OF TOP 5 MANUFACTURERS

CHAPTER 9. GLOBAL VETERINARY PAIN MANAGEMENT DRUGS MANUFACTURERS ANALYSIS
9.1. BOEHRINGER INGELHEIM
9.1.1. BUSINESS OVERVIEW
9.1.2. COMPANY BASIC INFORMATION
9.1.3. VETERINARY PAIN MANAGEMENT DRUGS PRODUCT DETAILS
9.1.4. BOEHRINGER INGELHEIM VETERINARY PAIN MANAGEMENT DRUGS PRODUCTION, REVENUE AND GROSS MARGIN

9.2. ZOETIS
9.2.1. BUSINESS OVERVIEW
9.2.2. COMPANY BASIC INFORMATION
9.2.3. VETERINARY PAIN MANAGEMENT DRUGS PRODUCT DETAILS
9.2.4. ZOETIS VETERINARY PAIN MANAGEMENT DRUGS PRODUCTION, REVENUE AND GROSS MARGIN

9.3. ELANCO
9.3.1. BUSINESS OVERVIEW
9.3.2. COMPANY BASIC INFORMATION
9.3.3. VETERINARY PAIN MANAGEMENT DRUGS PRODUCT DETAILS
9.3.4. ELANCO VETERINARY PAIN MANAGEMENT DRUGS PRODUCTION, REVENUE AND GROSS MARGIN

9.4. MERCK ANIMAL HEALTH
9.4.1. BUSINESS OVERVIEW
9.4.2. COMPANY BASIC INFORMATION
9.4.3. VETERINARY PAIN MANAGEMENT DRUGS PRODUCT DETAILS
9.4.4. MERCK ANIMAL HEALTH VETERINARY PAIN MANAGEMENT DRUGS PRODUCTION, REVENUE AND GROSS MARGIN

9.5. BAYER
9.5.1. BUSINESS OVERVIEW
9.5.2. COMPANY BASIC INFORMATION
9.5.3. VETERINARY PAIN MANAGEMENT DRUGS PRODUCT DETAILS
9.5.4. BAYER VETERINARY PAIN MANAGEMENT DRUGS PRODUCTION, REVENUE AND GROSS MARGIN

9.6. VETOQUINOL
9.6.1. BUSINESS OVERVIEW
9.6.2. COMPANY BASIC INFORMATION
9.6.3. VETERINARY PAIN MANAGEMENT DRUGS PRODUCT DETAILS
9.6.4. VETOQUINOL VETERINARY PAIN MANAGEMENT DRUGS PRODUCTION, REVENUE AND GROSS MARGIN

9.7. NORBROOK LABORATORIES
9.7.1. BUSINESS OVERVIEW
9.7.2. COMPANY BASIC INFORMATION
9.7.3. VETERINARY PAIN MANAGEMENT DRUGS PRODUCT DETAILS
9.7.4. NORBROOK LABORATORIES VETERINARY PAIN MANAGEMENT DRUGS PRODUCTION, REVENUE AND GROSS MARGIN

9.8. CEVA SANTÉ ANIMALE
9.8.1. BUSINESS OVERVIEW
9.8.2. COMPANY BASIC INFORMATION
9.8.3. VETERINARY PAIN MANAGEMENT DRUGS PRODUCT DETAILS
9.8.4. CEVA SANTÉ ANIMALE VETERINARY PAIN MANAGEMENT DRUGS PRODUCTION, REVENUE AND GROSS MARGIN

9.9. DECHRA PHARMACEUTICALS
9.9.1. BUSINESS OVERVIEW
9.9.2. COMPANY BASIC INFORMATION
9.9.3. VETERINARY PAIN MANAGEMENT DRUGS PRODUCT DETAILS
9.9.4. DECHRA PHARMACEUTICALS VETERINARY PAIN MANAGEMENT DRUGS PRODUCTION, REVENUE AND GROSS MARGIN

9.10. CHANELLE
9.10.1. BUSINESS OVERVIEW
9.10.2. COMPANY BASIC INFORMATION
9.10.3. VETERINARY PAIN MANAGEMENT DRUGS PRODUCT DETAILS
9.10.4. CHANELLE VETERINARY PAIN MANAGEMENT DRUGS PRODUCTION, REVENUE AND GROSS MARGIN

CHAPTER 10. VETERINARY PAIN MANAGEMENT DRUGS MARKET VALUE CHAIN ANALYSIS
10.1. VETERINARY PAIN MANAGEMENT DRUGS INDUSTRIAL CHAIN ANALYSIS
10.2. VETERINARY PAIN MANAGEMENT DRUGS KEY RAW MATERIALS ANALYSIS
10.2.1. KEY RAW MATERIALS
10.2.2. PRICE TREND OF KEY RAW MATERIALS
10.2.3. KEY SUPPLIERS OF RAW MATERIALS

•Boehringer Ingelheim
•Zoetis
•Elanco
•Merck Animal Health
•Bayer
•Vetoquinol
•Norbrook Laboratories
•Ceva Santé Animale
•Dechra Pharmaceuticals
•Chanelle

Select License Type

  • $4700
  • $5600
  • $2000
  • Buy Now

Report Highlights:

Complete overview of market
Major drivers, restrain, opportunities, and challenges of the market
Market Trends and how they are boosting the market growth
Changing dynamics in the Market
Complete overview of the market
Historical, Base year, projected, and current market size in terms of value and volume
COVID-19 Impact analysis of the market
Current industry trends and developments

CLIENTS